Sign in

CIK 0001812364 · Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
  1. 144 Insider Sale of Securities
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. 4 Open-market sale See remarks sold 17,083 shares at an average $3.68 ($62,947)
  7. 4 Open-market sale Chief Financial Officer sold 20,081 shares at an average $3.69 ($74,000)
  8. 4 Open-market sale President, R&D sold 30,770 shares at an average $3.69 ($113,478)
  9. 4 Open-market sale Chief Legal Officer sold 19,913 shares at an average $3.68 ($73,378)
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. 4 Open-market sale President and CEO sold 61,379 shares at $3.57 ($219,123)
  12. 4 Grant or award See remarks acquired 5,000 shares (grant or award)
  13. 4 Grant or award President and CEO acquired 5,000 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 8-K Event Executive or director change
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 6 of 28 · 556 filings